![Barbara-Jean Bormann-Kennedy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barbara-Jean Bormann-Kennedy
Directeur/Membre du Conseil chez
BIOLINERX LTD.
Fortune : 1 M $ au 31/08/2026
Profil
Dr. Barbara-Jean Bormann-Kennedy is an Independent Non-Executive Director at Xeris Biopharma Holdings, Inc. and an Independent Director at BioLineRx Ltd. She is on the Board of Directors at Xeris Biopharma Holdings, Inc., Nanomedical Systems, Inc., BioLineRx Ltd., Biotechnology Innovation Organization and Institute For Pediatric Innovation, Inc. Dr. Bormann-Kennedy was previously employed as an Independent Non-Executive Director by Xeris Pharmaceuticals, Inc., a VP-Translational Science & Network Alliances by The Jackson Laboratory, a President, Chief Executive Officer & Director by Pivot Pharmaceuticals, Inc., a Chief Executive Officer & Director by Harbour Antibodies BV, a Senior VP-Business Development & Licensing by Boehringer Ingelheim Pharmaceuticals, Inc., a Vice President-Strategic Alliances by Pfizer Inc., and a Consultant by Paperboy Ventures LLC.
She also served on the board at Supportive Therapeutics and Rincon Pharmaceuticals, Inc. She received her undergraduate degree from Fairfield University and a doctorate degree from the University of Connecticut Health Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/06/2026 | 150 693 ( 0,08% ) | 1 M $ | 31/08/2026 | |
BIOLINERX LTD. -.--% | 18/03/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Barbara-Jean Bormann-Kennedy
| Sociétés | Poste | Début |
|---|---|---|
| BIOLINERX LTD. | Directeur/Membre du Conseil | 19/08/2013 |
| XERIS BIOPHARMA HOLDINGS, INC. | Directeur/Membre du Conseil | 05/10/2021 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Institute For Pediatric Innovation, Inc.
 Institute For Pediatric Innovation, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Directeur/Membre du Conseil | - |
Nanomedical Systems, Inc.
 Nanomedical Systems, Inc. Medical SpecialtiesHealth Technology Develops silicon-based medical nanotechnology devices | Directeur/Membre du Conseil | 01/07/2021 |
Anciens postes connus de Barbara-Jean Bormann-Kennedy
| Sociétés | Poste | Fin |
|---|---|---|
The Jackson Laboratory
 The Jackson Laboratory BiotechnologyHealth Technology Operates as a nonprofit biomedical research institution | Corporate Officer/Principal | 01/02/2024 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Directeur/Membre du Conseil | 05/10/2021 |
Supportive Therapeutics
 Supportive Therapeutics Pharmaceuticals: MajorHealth Technology Supportive Therapeutics is a development stage pharmaceutical company focused on advancing promising medicines to reduce the serious side effects of cancer treatments. The company is based in Salisbury, MA and has subsidiaries in Australia. | Directeur Général | 01/07/2017 |
| BETTERLIFE PHARMA INC. | Directeur Général | 16/11/2015 |
| ░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Barbara-Jean Bormann-Kennedy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Rincon Pharmaceuticals, Inc.
 Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops human therapeutic proteins | Health Technology |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Nanomedical Systems, Inc.
Nanomedical Systems, Inc. Medical SpecialtiesHealth Technology Develops silicon-based medical nanotechnology devices | Health Technology |
BetterLife Pharma, Inc.
 BetterLife Pharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of therapeutic pharmaceutical products | Health Technology |
Fairfield University
 Fairfield University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut Health Center
 University of Connecticut Health Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Jackson Laboratory
The Jackson Laboratory BiotechnologyHealth Technology Operates as a nonprofit biomedical research institution | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Paperboy Ventures LLC
 Paperboy Ventures LLC Investment ManagersFinance Paperboy Ventures focuses on investments in seed and early-stage life science, applied technology and scientific discovery companies. The firm looks for companies with strong intellectual property, a revolutionary science or technology and experienced management teams. Seed investments are generally under $1 million and early-stage investments range from $1 million to $5 million. Paperboy Ventures seeks to take an active role in their portfolio companies. The firm often leads financing rounds but will also co-invest. They reserve additional capital to help milestone-achieving companies scale up quickly | Finance |
BioLineRx Ltd.
 BioLineRx Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes cell transplantation products | Health Technology |
Harbour Antibodies BV
 Harbour Antibodies BV Medical/Nursing ServicesHealth Services Engages in the production of antibodies and VH domains for therapy | Health Services |
Institute For Pediatric Innovation, Inc.
Institute For Pediatric Innovation, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Supportive Therapeutics
Supportive Therapeutics Pharmaceuticals: MajorHealth Technology Supportive Therapeutics is a development stage pharmaceutical company focused on advancing promising medicines to reduce the serious side effects of cancer treatments. The company is based in Salisbury, MA and has subsidiaries in Australia. | Health Technology |
Xeris Biopharma Holdings, Inc.
 Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
